TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 52.30
+0.10 (0.19%)
Sep 19, 2025, 12:58 PM CST
TSH Biopharm Corporation Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 114.76 | 113.09 | 61.99 | 61.89 | 47.11 | 61.57 | Upgrade |
Depreciation & Amortization | 26.88 | 27.56 | 21.34 | 20.61 | 9.65 | 9.54 | Upgrade |
Other Amortization | 1.45 | 1.4 | 1.23 | 0.91 | 0.14 | 0.11 | Upgrade |
Loss (Gain) From Sale of Assets | -0.25 | 0.87 | 0.04 | 0.06 | 0 | - | Upgrade |
Asset Writedown & Restructuring Costs | 8.8 | 8.8 | - | - | 4.15 | 4.58 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | - | 1.56 | Upgrade |
Provision & Write-off of Bad Debts | -0.45 | 0.76 | -1.93 | 3.04 | -0.1 | -0.1 | Upgrade |
Other Operating Activities | 32.17 | 35.14 | -8.83 | -1.3 | -15.64 | 0.95 | Upgrade |
Change in Accounts Receivable | -6.48 | 48.61 | -5.52 | -10.41 | 9.05 | 5.14 | Upgrade |
Change in Inventory | 10.33 | -44.91 | -11.01 | -13.95 | 4.69 | -18.85 | Upgrade |
Change in Accounts Payable | -0.52 | -43.14 | -5.93 | -49.46 | 6.33 | -34.66 | Upgrade |
Change in Unearned Revenue | 3.21 | -0.8 | -3.59 | 5.23 | - | -2.48 | Upgrade |
Change in Other Net Operating Assets | -6.96 | 36.4 | -13.93 | 17.74 | 3.34 | -15.74 | Upgrade |
Operating Cash Flow | 182.92 | 183.77 | 33.87 | 34.35 | 68.71 | 11.61 | Upgrade |
Operating Cash Flow Growth | 136.71% | 442.54% | -1.40% | -50.00% | 491.74% | -86.90% | Upgrade |
Capital Expenditures | -4.97 | -1.73 | -5.38 | -3.73 | -0.38 | -1.92 | Upgrade |
Sale of Property, Plant & Equipment | 0.3 | 0.3 | - | 0.03 | - | - | Upgrade |
Cash Acquisitions | - | -242.87 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -6 | -1.02 | -0.18 | -15 | - | -0.46 | Upgrade |
Investment in Securities | 13.63 | 127.94 | 167.87 | 44.67 | -14.28 | 229.43 | Upgrade |
Other Investing Activities | 7.36 | 6.99 | -1.29 | 7.42 | 4.6 | 7.16 | Upgrade |
Investing Cash Flow | 11.79 | -110.38 | 161.02 | 33.4 | -10.06 | 234.21 | Upgrade |
Short-Term Debt Issued | - | - | - | 20 | - | - | Upgrade |
Long-Term Debt Issued | - | - | - | 30 | - | - | Upgrade |
Total Debt Issued | - | - | - | 50 | - | - | Upgrade |
Short-Term Debt Repaid | - | - | -20 | -61.07 | - | - | Upgrade |
Long-Term Debt Repaid | - | -12.54 | -35.73 | -20.93 | -4.35 | -4.22 | Upgrade |
Total Debt Repaid | -12.98 | -12.54 | -55.73 | -82 | -4.35 | -4.22 | Upgrade |
Net Debt Issued (Repaid) | -12.98 | -12.54 | -55.73 | -32 | -4.35 | -4.22 | Upgrade |
Common Dividends Paid | -49.15 | -49.15 | -61.44 | -57.6 | -69.12 | -69.12 | Upgrade |
Other Financing Activities | - | - | 9.99 | 0.2 | - | - | Upgrade |
Financing Cash Flow | -62.13 | -61.69 | -107.18 | -89.4 | -73.46 | -73.33 | Upgrade |
Foreign Exchange Rate Adjustments | 0.01 | 0.06 | -0.03 | 0.03 | - | - | Upgrade |
Net Cash Flow | 132.6 | 11.76 | 87.68 | -21.62 | -14.81 | 172.49 | Upgrade |
Free Cash Flow | 177.95 | 182.04 | 28.49 | 30.62 | 68.33 | 9.7 | Upgrade |
Free Cash Flow Growth | 135.92% | 538.93% | -6.96% | -55.18% | 604.75% | -88.68% | Upgrade |
Free Cash Flow Margin | 14.40% | 16.32% | 3.51% | 4.13% | 16.52% | 2.17% | Upgrade |
Free Cash Flow Per Share | 4.63 | 4.74 | 0.74 | 0.80 | 1.78 | 0.25 | Upgrade |
Cash Interest Paid | 0.71 | 0.46 | 0.69 | 0.7 | 0.08 | 0.03 | Upgrade |
Cash Income Tax Paid | 42.88 | 19.24 | 15.9 | 13.98 | 23.74 | 8.29 | Upgrade |
Levered Free Cash Flow | 302.88 | 138.94 | 8.75 | -18.85 | 62.7 | -1.52 | Upgrade |
Unlevered Free Cash Flow | 303.32 | 139.23 | 9.18 | -18.41 | 62.75 | -1.5 | Upgrade |
Change in Working Capital | -0.43 | -3.84 | -39.97 | -50.86 | 23.41 | -66.6 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.